Massive study to test if stopping popular diabetes drugs before a scope prevents stomach issues
NCT ID NCT07276763
First seen Dec 24, 2025 · Last updated May 22, 2026 · Updated 20 times
Summary
This study looks at whether stopping GLP-1 receptor agonists (a type of diabetes medication) for two weeks before an upper endoscopy lowers the chance of food staying in the stomach. Researchers will review medical records from over 16,500 patients to compare those who paused the drug with those who did not. The goal is to find out if this simple step makes the procedure safer and more effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC RETENTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Huadong hospital, Fudan university
Shanghai, Shanghai Municipality, 200040, China
Conditions
Explore the condition pages connected to this study.